Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

The study supports prior research that found the same thing.

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The first GLP-1 pill could be in medicine cabinets sooner than expected. Eli Lilly (LLY) announced Thursday that its daily ...

Certain foods can worsen GI side effects from GLP-1 durgs. Learn which foods to avoid and which to choose instead.

Former speed skater Sarah Lindsay believes injections such as Ozempic and Mounjaro — known ... sick “or even a comeback of a deficiency disease like scurvy”. The illness is caused by a ...

Pfizer has stopped the development of its weight loss pill after a patient experienced a liver injury that was potentially ...

None had been diagnosed with Alzheimer disease and related dementias at the start of the study. The researchers discovered that people who took GLP-1 receptor agonists (like Ozempic) or a type of ...

She warned that the jabs could make people ill or even a cause a 'comeback of a deficiency disease like scurvy'. Weight loss drugs such as Ozempic, Wegovy and Mounjaro are all injectable GLP-1 ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

Ozempic, initially for type 2 diabetes, has gained popularity for rapid weight loss, leading to a newly reported side effect ...